Safety of Hendra virus anti-G glycoprotein monoclonal antibody in humans (2012–2013)
- Abstract:
- Hendra virus infection in humans is a serious, and often fatal, disease. No cure exists for Hendra infection and existing treatments are ineffective. Recently, a human monoclonal antibody has shown great promise in protecting animals from developing the disease. This project aims to perform preclinical safety testing and a Phase I clinical trial to establish the safety profile of this antibody such that it can be used to prevent Hendra infection in humans exposed to the disease.
- Grant type:
- NHMRC Targeted Research
- Researchers:
-
-
Professorial Research Fellow
Australian Institute for Bioengineering and Nanotechnology -
Emeritus Professor
Australian Institute for Bioengineering and Nanotechnology -
-
- Funded by:
- National Health and Medical Research Council
